申请人:Aton Pharma, Inc.
公开号:US20140350284A1
公开(公告)日:2014-11-27
Provided herein are compositions including diastereomers in substantially diastereomerically pure form and enantiomers in substantially enantiomerically pure form, and processes for preparing them and converting them to metyrosine.
本文提供的是包含基本上对映异构体纯度的顺反异构体和基本上对映体纯度的对映体的组合物,以及制备它们和将它们转化为甲基酪氨酸的过程。